Figure 3. Model output for the Uganda HMM programme using CQ+SP from a provider perspective.

The model suggests that HMM will only be efficient in areas of medium and high transmission, where the probability of appropriate care is low. In low transmission areas HMM is more effective but too costly, and is not cost-effective. CQ+SP  =  chloroquine + sulfadoxine-pyrimethamine.